KLK3 and Familial prostate cancer: Prostate-specific antigen (PSA) based screening has been adopted in several developed countries since 1990's, and downward trend of mortality rate from prostate cancer has been demonstrated in quite a few countries like United States of America (USA) (10), Canada (11), United Kingdom (UK) (12), and Japan (13).